Acetylcholinesterase inhibitors


Avoid with symptomatic bradycardia and syncope. These inhibitors should be avoided in patients with symptomatic bradycardia and syncope as these medications can cause or exacerbate these conditions.

Resources

University of Sydney in conjunction with the Bruyère Research Institute (Canada)

Primary Health Tasmania

Leave a Reply